Lnc2Cancer

Experimentally Supported Human LncRNA and Cancer Associations Database

LncRNA centric

Cancer centric

Advanced search

Drug resistant

Circulating

Prognosis

Detail


   LncRNA Name HNF1A-AS1
   Synonyms HNF1A-AS1, C12orf27, NCRNA00262, FLJ38690, HAS1
   Region GRCh38_12:120941728-120980965    Sequence
   Ensembl ENSG00000241388
   RefSeq NR_024345
   Circulating
   Drug-resisitant
   Prognostic
   MiRNA
   Variant
   TF
   Methylation
   Cancer Name hepatocellular carcinoma
   ICD-0-3 C22.0  M8170/3
   Methods Microarray, RT-PCR, Western blot, Luciferase reporter assay, in vitro knockdown, RIP
   Sample human HCC cell lines (Huh-7, MHCC-97 L, MHCC-97H, MHCC-LM3, SMMC-7721 and YY-8103 ),
   Expression Pattern down-regulated
   Function Description

HNF1a activated the transcription of HNF1A-AS1 by directly binding to its promoter region. HNF1A-AS1 inhibited the growth and the metastasis of HCC cells in vitro and in vivo. Moreover, knockdown of HNF1A-AS1 reversed the suppressive effects of HNF1a on the migration and invasion of HCC cells. Importantly, HNF1A-AS1 directly bound to the C-terminal of SHP-1 with a high binding affinity (KD=59.57±14.29nM) and increased the phosphatase activity of SHP-1. Inhibition of SHP-1 enzymatic activity substantially reversed the HNF1a- or HNF1A-AS1-induced reduction on the metastatic property of HCC cells.

   Pubmed ID 29466992
   Year 2018
   Title The HNF1a-regulated lncRNA HNF1A-AS1 reverses the malignancy of hepatocellular carcinoma by enhancing the phosphatase activity of SHP-1.
   External Links
   Links for  HNF1A-AS1 GenBank       HGNC       lncrnadb       Noncode
   Links for  hepatocellular carcinoma Omim       Cosmic

CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.